S E Vollset

Summary

Affiliation: University of Bergen
Country: Norway

Publications

  1. ncbi Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study
    S E Vollset
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Bergen, Norway
    Am J Clin Nutr 74:130-6. 2001
  2. ncbi Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study
    S E Vollset
    Section for Medical Statistics, The Department of Public Health and Primary Health Care, Norway
    Am J Clin Nutr 71:962-8. 2000
  3. ncbi Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study
    L El-Khairy
    Department of Public Health and Primary Health Care and the Department of Pharmacology, University of Bergen, Norway
    Am J Clin Nutr 70:1016-24. 1999
  4. ncbi Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study
    O Nygard
    Department of Public Health and Primary Health Care, University of Bergen, Norway
    Am J Clin Nutr 67:263-70. 1998
  5. ncbi Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study
    E Nurk
    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    QJM 99:289-98. 2006
  6. ncbi Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study
    O Nygard
    Department of Clinical Biology, University of Bergen, Norway
    Am J Clin Nutr 65:136-43. 1997
  7. ncbi Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians
    H Refsum
    Department of Pharmacology and the Locus for Homocysteine and Related Vitamins, University of Bergen, Norway
    Am J Clin Nutr 74:233-41. 2001
  8. ncbi The Hordaland Homocysteine Studies
    P M Ueland
    LOCUS for Homocysteine and Related Vitamins, Armauer Hansens Hus, University of Bergen, Norway
    Lipids 36:S33-9. 2001
  9. ncbi Homocysteine and cardiovascular disease
    H Refsum
    Department of Pharmacology, University of Bergen, Norway
    Annu Rev Med 49:31-62. 1998
  10. ncbi Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism
    S Hustad
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Armauer Hansens Hus, N 5021 Bergen, Norway
    Clin Chem 46:1065-71. 2000

Collaborators

Detail Information

Publications27

  1. ncbi Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study
    S E Vollset
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Bergen, Norway
    Am J Clin Nutr 74:130-6. 2001
    ..Few population-based studies have assessed relations between plasma or serum total homocysteine (tHcy) and all-cause mortality...
  2. ncbi Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study
    S E Vollset
    Section for Medical Statistics, The Department of Public Health and Primary Health Care, Norway
    Am J Clin Nutr 71:962-8. 2000
    ..Total homocysteine (tHcy) measured in serum or plasma is a marker of folate status and a risk factor for cardiovascular disease...
  3. ncbi Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study
    L El-Khairy
    Department of Public Health and Primary Health Care and the Department of Pharmacology, University of Bergen, Norway
    Am J Clin Nutr 70:1016-24. 1999
    ..Cysteine is structurally and metabolically related to homocysteine, but data on its association with cardiovascular disease and cardiovascular disease risk factors are sparse...
  4. ncbi Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study
    O Nygard
    Department of Public Health and Primary Health Care, University of Bergen, Norway
    Am J Clin Nutr 67:263-70. 1998
    ..These findings are relevant for establishing adequate reference ranges for tHcy and emphasize folate intake, smoking status, and coffee consumption as major acquired determinants of tHcy concentration in this general population...
  5. ncbi Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study
    E Nurk
    Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    QJM 99:289-98. 2006
    ..The factor V Leiden (FVL) mutation is the most common cause of inherited thrombophilia in Caucasian populations, and women with this variant allele are at increased risk for pregnancy complications...
  6. ncbi Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study
    O Nygard
    Department of Clinical Biology, University of Bergen, Norway
    Am J Clin Nutr 65:136-43. 1997
    ..The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption...
  7. ncbi Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians
    H Refsum
    Department of Pharmacology and the Locus for Homocysteine and Related Vitamins, University of Bergen, Norway
    Am J Clin Nutr 74:233-41. 2001
    ..In India, most people adhere to a vegetarian diet, which may lead to cobalamin deficiency...
  8. ncbi The Hordaland Homocysteine Studies
    P M Ueland
    LOCUS for Homocysteine and Related Vitamins, Armauer Hansens Hus, University of Bergen, Norway
    Lipids 36:S33-9. 2001
    ..The Hordaland Homocysteine cohort will be used for future investigations of the stability of tHcy and vitamin status over time, and to investigate associations with mortality and morbidity including cancer incidence...
  9. ncbi Homocysteine and cardiovascular disease
    H Refsum
    Department of Pharmacology, University of Bergen, Norway
    Annu Rev Med 49:31-62. 1998
    ..Supplementation with B-vitamins, in particular with folic acid, is an efficient, safe, and inexpensive means to reduce an elevated tHcy level. Studies are now in progress to establish whether such therapy will reduce cardiovascular risk...
  10. ncbi Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism
    S Hustad
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Armauer Hansens Hus, N 5021 Bergen, Norway
    Clin Chem 46:1065-71. 2000
    ..This motivates the investigation of the possible relationship between riboflavin status and tHcy...
  11. ncbi Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials
    M Ebbing
    Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
    J Intern Med 268:367-82. 2010
    ....
  12. ncbi Biological and clinical implications of the MTHFR C677T polymorphism
    P M Ueland
    LOCUS for Homocysteine and Related Vitamins, Armauer Hanssens hus, University of Bergen, 5021, Bergen, Norway
    Trends Pharmacol Sci 22:195-201. 2001
    ....
  13. ncbi The controversy over homocysteine and cardiovascular risk
    P M Ueland
    LOCUS for Homocysteine and Related Vitamins, Armauer Hansens Hus, University of Bergen, Norway
    Am J Clin Nutr 72:324-32. 2000
    ..Thus, only placebo-controlled intervention studies with tHcy-lowering B vitamins and clinical endpoints can provide additional valid arguments for the debate over whether tHcy is a causal CVD risk factor...
  14. ncbi Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register
    S A Lie
    Division for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Sykehus, Norway
    Acta Orthop Scand 71:19-27. 2000
    ..65). During the first 60 postoperative days, all patient categories had a higher mortality than the general population (0.8% mortality, SMR = 1.39)...
  15. ncbi Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
    Ø Bleie
    Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
    J Intern Med 262:244-53. 2007
    ..We wanted to test the effect of homocysteine-lowering B-vitamin therapy, as used in the Western Norway B-vitamin Intervention Trial (WENBIT), on inflammatory markers associated with atherosclerosis...
  16. ncbi Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project
    L El-Khairy
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Bergen, Norway
    Circulation 103:2544-9. 2001
    ..We studied the relation between plasma total cysteine (tCys) levels and the risk of vascular disease in the coronary, cerebral, and peripheral vessels...
  17. ncbi Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets
    J Schneede
    Department of Pharmacology and Toxicology, University of Bergen, Haukeland Hospital, Norway
    Pediatr Res 36:194-201. 1994
    ..Furthermore, the finding of high methylmalonic acid and total homocysteine in plasma of most macrobiotic infants demonstrates a functional cobalamin deficiency in these subjects...
  18. ncbi Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Hhomocysteine Sstudy
    E Nurk
    Department of Public Health and Primary Health Care, University of Bergen, N 5021 Bergen, Norway
    J Nutr 131:1214-6. 2001
    ....
  19. ncbi Total homocysteine and cardiovascular disease
    O Nygard
    Division for Medical Statistics, Department of Public Health, University of Bergen, Norway, Sweden
    J Intern Med 246:425-54. 1999
    ..This paper reviews the biochemical, clinical, epidemiological and experimental data underlying this conclusion and is critically questioning whether elevated tHcy is a causal factor...
  20. ncbi Determinants of cobalamin status in newborns
    A L Bjørke Monsen
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Bergen, Norway
    Pediatrics 108:624-30. 2001
    ..We investigated the relation between cobalamin status in newborns and in their healthy mothers who consumed an omnivorous diet...
  21. ncbi Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study
    B E Vikse
    Renal Research Group, Institute of Medicine, University of Bergen, Norway
    Scand J Clin Lab Invest 64:709-22. 2004
    ..The purpose of the present study was to investigate determinants of serum creatinine in the general population...
  22. ncbi Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking
    B G Nedrebø
    LOCUS for Homocysteine and Related Vitamins, University of Bergen, Haukeland University Hospital, Bergen, Norway
    J Intern Med 254:504-12. 2003
    ..To investigate plasma total homocysteine levels and its relation to B-vitamins and smoking in Graves' disease before and after antithyroid therapy...
  23. ncbi Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99
    O Furnes
    Haukeland University Hospital, Bergen, Norway
    J Bone Joint Surg Br 83:579-86. 2001
    ..If a cemented Charnley prosthesis is used, the type of disease leading to THR seems in most cases to have only a minor influence on the survival of the prosthesis...
  24. ncbi Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register
    S A Lie
    Section for Medical Statistics, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    J Bone Joint Surg Br 86:504-9. 2004
    ..Recementation without allograft, and uncemented revision with bone impaction, were associated with worse results than the other revision techniques which we studied...
  25. ncbi Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice
    E Ulvestad
    Department of Microbiology and Immunology, The Gade Institute, Haukeland University Hospital, Bergen, Norway
    Scand J Immunol 52:309-15. 2000
    ..At the given cut-off values indirect immunofluorescence on HEp-2 cells performed best. All assays except mouse kidney showed performance characteristics sufficient for use in routine analysis of ANA...
  26. ncbi Cerebrospinal fluid proteins as indicators of nerve root compression in patients with sciatica caused by disc herniation
    J S Skouen
    Department of Neurology, Haukeland University Hospital, Bergen, Norway
    Spine (Phila Pa 1976) 18:72-9. 1993
    ..The cerebrospinal fluid proteins may be used as diagnostic parameters of nerve root compression, especially when surgery is a consideration or in patients in whom sciatica is unlikely...
  27. ncbi Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum
    A Ulvik
    LOCUS for Homocysteine and Related Vitamins, Armauer Hansens Hus, University of Bergen, Bergen, Norway
    Am J Med Genet 101:246-54. 2001
    ..In conclusion, in smokers, high folate status may confer increased or decreased risk for HRAs, depending on the MTHFR genotype. These data demonstrate the strong gene-nutrition interaction involving the C677T MTHFR polymorphism...